red leicester
Selected indexed studies
- Global Burden of Cardiovascular Diseases and Risks, 1990-2022. (J Am Coll Cardiol, 2023) [PMID:38092509]
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. (N Engl J Med, 2023) [PMID:37622681]
- Eosinophilic inflammation in COPD: prevalence and clinical characteristics. (Eur Respir J, 2014) [PMID:25323230]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Global Burden of Cardiovascular Diseases and Risks, 1990-2022. (2023) pubmed
- Benralizumab for the Prevention of COPD Exacerbations. (2019) pubmed
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. (2023) pubmed
- Eosinophilic inflammation in COPD: prevalence and clinical characteristics. (2014) pubmed
- Improving lung health in low-income and middle-income countries: from challenges to solutions. (2021) pubmed
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. (2018) pubmed
- Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision. (2024) pubmed
- The multiomics blueprint of the individual with the most extreme lifespan. (2025) pubmed
- Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. (2020) pubmed
- Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. (2021) pubmed